0002-2236 : Trulicity 3 mg/.5ml Subcutaneous Injection, Solution
NDC: | 0002-2236 |
Labeler: | Eli Lilly and Company |
Product Type: | Human Prescription Drug |
Drug Name: | Trulicity |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA125469 |
Rev. Date: |
NDC Package Codes:
- 0002-2236-61: 2 SYRINGE IN 1 CARTON (0002‑2236‑61) > .5 ML IN 1 SYRINGE
- 0002-2236-80: 4 SYRINGE IN 1 CARTON (0002‑2236‑80) > .5 ML IN 1 SYRINGE (0002‑2236‑01)
Active Ingredients:
- Dulaglutide
Dosage Strength:
- 3 mg/.5mL
Pharmaceutical Classes:
- GLP-1 Receptor Agonist [EPC]
- Glucagon-Like Peptide 1 [CS]
- Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
Related Products:
Based on records with the same trade name.- 0002-1433 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
- 0002-1434 Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
- 0002-3182 Trulicity 4.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company
- 50090-3483 Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
- 50090-3484 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
- 50090-5467 Trulicity 3 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
- 50090-6453 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
- 50090-6456 Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
- 50090-6571 Trulicity 3 mg/.5ml Subcutaneous Injection, Solution by A-s Medication Solutions
- 54568-433 Trulicity .75 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly Italia Spa
- 54568-434 Trulicity 1.5 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly Italia Spa
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0002-2214Next: 0002-2340 >
Related Discussions:
Trulicity For Diabetes
Starting in mid-July will Trulicity (0.75mg) be available? It is marketed for use in treating type 2 diabetes. ## It is ... 1 reply
Starting in mid-July will Trulicity (0.75mg) be available? It is marketed for use in treating type 2 diabetes. ## It is ... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.